CEO and President
Michael Garippa is the former CEO and President of TandemHeart. He was recruited by TandemHeart in 2002 as a turnaround expert and stayed on as CEO and President. He took TandemHeart from an R&D firm that had lost an aggregate of $50 million and had no commercial sales to a successful company with over $6 million in net income in the 24 months prior to joining SynCardia.
Prior to joining TandemHeart, Mr. Garippa served as CEO and President of Gateway Home Care. In addition, Mr. Garippa was Founder and CEO of Millennium HomeCare and The Prompt Care Companies. His background also includes being National Sales Manager at Omni Medical and Senior Analyst with the NYC Health and Hospitals Corporation. Mr. Garippa holds a B.A. degree from Rutgers University and a master's degree from New York University.
Chief Development Officer
Douglas Nutter joined SynCardia in March 2012. He has 20+ years of experience in materials, operations and management with GE Plastics. As President of Exatec, LLC, he led the formation, negotiation and start-up of a joint venture between GE and Bayer for lightweight, life-saving polycarbonate automotive windows. Mr. Nutter also has 10 years of experience in optics-based medical devices as Vice President of Business Development at Optical Research Associates, and General Manager of Electro-Optics at Zygo Corporation. He received an S.B. in Physics from MIT and began his career as a materials physicist for Hercules.
Chief Financial Officer
Kirk Collamer brings diverse U.S. and international experience to SynCardia, with over 30 years in finance, accounting, information systems, planning and audit with Fortune 500, growth and startup companies in biotechnology, networked, service, consumer products and manufacturing companies at the division, group, corporate, and Board of Director levels. He led 3 IPO's and numerous public and private financings, raising over $1B in equity and debt capital. Kirk started his career at Arthur Andersen & Co., served in senior level management, finance and accounting positions at Brown-Forman, Ameritech, Muzak, Coinstar, and most recently as Vice President and Chief Financial Officer of HTG Molecular Diagnostics, Inc. Kirk received a B.A. in Accounting from Michigan State University and his MBA from Vanderbilt University. He is a Certified Public Accountant.
Executive Vice President, Global Commercialization
On January 5, 2015, Tim Shannon joined SynCardia Systems, Inc. as Executive Vice President, Global Commercialization. Mr. Shannon brings more than 25 years of global sales, marketing and operational expertise within the medical device space. He most recently was senior vice president of worldwide sales and marketing for Response Biomedical Corp., which develops and manufactures rapid on-site diagnostic tests primarily for the diagnosis of acute myocardial infarction and congestive heart failure. He has held senior-level roles with Boston Scientific Corp., General Electric Healthcare, U.S. Surgical Corp. and Teleflex, Inc., where he managed its $225-million Vascular Products portfolio. Additionally, Shannon sits on the Board of Directors for SystemsMerge, Inc., an Orlando-based and privately held medical informatics company. Mr. Shannon holds a bachelor of science/business administration in marketing from the University of Central Florida.
Luis Burgos joined us as our Vice President in April 2014. Mr. Burgos has over 20 years of experience in turnaround and general management, operations, strategic planning, quality and FDA regulatory compliance in the medical device industry with start-ups and Fortune 500 companies such as Kimberly Clark, Westmed Inc. and Helix Medical. Mr. Burgos holds a B.S. in Industrial and Systems Engineering from I.T.E.S.M. Monterrey Institute of Technology & Higher Education and a MBA in International Business from U.I.A. Latin American University.
NEXT ›› Board of Directors